CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Open-market buy CEO bought 820,826 shares at an average $0.49 ($406,149)
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 500,000 shares at $0.66 ($330,000)
- 4 Gift CEO gave 10,813 shares (gift)
- 4 Open-market sale Medical Director sold 50,900 shares at an average $0.55 ($27,998)
- 4 Open-market buy Medical Director bought 230,586 shares at $0.58 ($132,587)
- 4 Open-market buy Vice President of Operations bought 185,748 shares at $0.59 ($109,777)
- 4 Open-market buy Chief Financial Officer bought 198,135 shares at $0.59 ($117,296)
- 4 Gift CEO gave 5,000 shares (gift)
- 4 Gift CEO gave 5,000 shares (gift)
- 4 Gift CEO gave 20,000 shares (gift)
- 4 Open-market buy Vice President of Operations bought 877 shares at $0.56 ($493)
- 4 Open-market buy Senior Vice President bought 2,500 shares at $0.64 ($1,600)
- 4 Open-market buy Medical Director bought 12,000 shares at $0.57 ($6,785)
- 4 Open-market buy CFO bought 2,000 shares at $0.56 ($1,126)
- 4 Open-market buy CEO bought 30,000 shares at $0.57 ($17,070)
- 4 Grant or award Director acquired 19,455 shares (grant or award)
- 4 Gift CEO gave 3,630 shares (gift)
- 4 Gift CEO gave 14,900 shares (gift)
Page 23 of 31 · 616 filings